Radiotherapy of primary cutaneous CD30+ large cell lymphoma. A preliminary study of eight patients

R. Piccinno, M. Caccialanza, E. Berti, M. Beretta, L. Gnecchi

Research output: Contribution to journalArticle

Abstract

Cutaneous CD30+ lymphomas are a group of lymphoproliferative disorders classified recently. Within this group the form of primary cutaneous CD30+ large cell lymphomas, characterized by the onset of solitary or localized nodules, seems to have a favourable course, sometimes with spontaneous regression. Thus, a nonaggressive treatment is a first-choice therapeutic approach. Dermatological radiotherapy using contact, soft or half-deep X-rays was performed on eight patients in the period 1991-1995, with a median total dose of 20 Gy per field of irradiation. The mean follow-up was of 24.75 months. All the lesions treated healed completely and up to now no relapse has been observed in the irradiated areas. Radiotherapy was always well tolerated and the cosmetic results were good in six patients (75%) and acceptable in two (25%). The preliminary results in this small series of patients support the choice of dermatological radiotherapy in the treatment of primary cutaneous CD30+ large cell lymphomas with solitary or few lesions.

Original languageEnglish
Pages (from-to)183-185
Number of pages3
JournalJournal of Dermatological Treatment
Volume7
Issue number3
Publication statusPublished - 1996

Fingerprint

Lymphoma
Radiotherapy
Skin
Lymphoproliferative Disorders
Cosmetics
Therapeutics
X-Rays
Recurrence

Keywords

  • Cutaneous CD30 lymphoma
  • Radiotherapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Radiotherapy of primary cutaneous CD30+ large cell lymphoma. A preliminary study of eight patients. / Piccinno, R.; Caccialanza, M.; Berti, E.; Beretta, M.; Gnecchi, L.

In: Journal of Dermatological Treatment, Vol. 7, No. 3, 1996, p. 183-185.

Research output: Contribution to journalArticle

@article{60d9547e8b844c0592fa835d8d4b5881,
title = "Radiotherapy of primary cutaneous CD30+ large cell lymphoma. A preliminary study of eight patients",
abstract = "Cutaneous CD30+ lymphomas are a group of lymphoproliferative disorders classified recently. Within this group the form of primary cutaneous CD30+ large cell lymphomas, characterized by the onset of solitary or localized nodules, seems to have a favourable course, sometimes with spontaneous regression. Thus, a nonaggressive treatment is a first-choice therapeutic approach. Dermatological radiotherapy using contact, soft or half-deep X-rays was performed on eight patients in the period 1991-1995, with a median total dose of 20 Gy per field of irradiation. The mean follow-up was of 24.75 months. All the lesions treated healed completely and up to now no relapse has been observed in the irradiated areas. Radiotherapy was always well tolerated and the cosmetic results were good in six patients (75{\%}) and acceptable in two (25{\%}). The preliminary results in this small series of patients support the choice of dermatological radiotherapy in the treatment of primary cutaneous CD30+ large cell lymphomas with solitary or few lesions.",
keywords = "Cutaneous CD30 lymphoma, Radiotherapy",
author = "R. Piccinno and M. Caccialanza and E. Berti and M. Beretta and L. Gnecchi",
year = "1996",
language = "English",
volume = "7",
pages = "183--185",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Radiotherapy of primary cutaneous CD30+ large cell lymphoma. A preliminary study of eight patients

AU - Piccinno, R.

AU - Caccialanza, M.

AU - Berti, E.

AU - Beretta, M.

AU - Gnecchi, L.

PY - 1996

Y1 - 1996

N2 - Cutaneous CD30+ lymphomas are a group of lymphoproliferative disorders classified recently. Within this group the form of primary cutaneous CD30+ large cell lymphomas, characterized by the onset of solitary or localized nodules, seems to have a favourable course, sometimes with spontaneous regression. Thus, a nonaggressive treatment is a first-choice therapeutic approach. Dermatological radiotherapy using contact, soft or half-deep X-rays was performed on eight patients in the period 1991-1995, with a median total dose of 20 Gy per field of irradiation. The mean follow-up was of 24.75 months. All the lesions treated healed completely and up to now no relapse has been observed in the irradiated areas. Radiotherapy was always well tolerated and the cosmetic results were good in six patients (75%) and acceptable in two (25%). The preliminary results in this small series of patients support the choice of dermatological radiotherapy in the treatment of primary cutaneous CD30+ large cell lymphomas with solitary or few lesions.

AB - Cutaneous CD30+ lymphomas are a group of lymphoproliferative disorders classified recently. Within this group the form of primary cutaneous CD30+ large cell lymphomas, characterized by the onset of solitary or localized nodules, seems to have a favourable course, sometimes with spontaneous regression. Thus, a nonaggressive treatment is a first-choice therapeutic approach. Dermatological radiotherapy using contact, soft or half-deep X-rays was performed on eight patients in the period 1991-1995, with a median total dose of 20 Gy per field of irradiation. The mean follow-up was of 24.75 months. All the lesions treated healed completely and up to now no relapse has been observed in the irradiated areas. Radiotherapy was always well tolerated and the cosmetic results were good in six patients (75%) and acceptable in two (25%). The preliminary results in this small series of patients support the choice of dermatological radiotherapy in the treatment of primary cutaneous CD30+ large cell lymphomas with solitary or few lesions.

KW - Cutaneous CD30 lymphoma

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0029861889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029861889&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029861889

VL - 7

SP - 183

EP - 185

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 3

ER -